Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 10.16% is 38% above its 5-year average of 7.35%, near the high end of its 5-year range (0.00%–10.89%).
As of the fiscal period ended Wednesday, December 31, 2025. 43.10% above its 12-month average of 7.10%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
10.16%
RETURN ON ASSETS (ROA) AVG TTM
7.10%
RETURN ON ASSETS (ROA) AVG 3Y
8.43%
RETURN ON ASSETS (ROA) AVG 5Y
7.35%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+43.10%
CURRENT VS 3Y AVG
+20.49%
CURRENT VS 5Y AVG
+38.23%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.93%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+106.09%
vs the sector median at left
Solventum Corporation
Market Cap
$13.83B
Return on Assets (ROA)
10.16%
TTM Avg
7.10%
3Y Avg
8.43%
5Y Avg
7.35%
Market Cap
$13.88B
Return on Assets (ROA)
1.89%
TTM Avg
3.10%
3Y Avg
3.02%
5Y Avg
7.71%
Market Cap
$12.31B
Return on Assets (ROA)
2.01%
TTM Avg
2.19%
3Y Avg
1.89%
5Y Avg
3.83%
Market Cap
$12.29B
Return on Assets (ROA)
6.81%
TTM Avg
6.68%
3Y Avg
6.69%
5Y Avg
12.75%
Market Cap
$11.93B
Return on Assets (ROA)
-5.53%
TTM Avg
-3.64%
3Y Avg
-1.62%
5Y Avg
0.47%
Market Cap
$11.65B
Return on Assets (ROA)
10.14%
TTM Avg
10.65%
3Y Avg
7.37%
5Y Avg
5.11%
Market Cap
$11.22B
Return on Assets (ROA)
4.30%
TTM Avg
4.54%
3Y Avg
7.94%
5Y Avg
8.21%
Market Cap
$16.70B
Return on Assets (ROA)
23.89%
TTM Avg
21.05%
3Y Avg
19.32%
5Y Avg
16.45%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $13.83B | 10.16% | 7.10% | 8.43% | 7.35% |
| The Cooper Companies, Inc. (COO)vs › | $13.88B | 1.89% | 3.10% | 3.02% | 7.71% |
| DaVita Inc. (DVA)vs › | $15.31B | 4.47% | 4.84% | 4.27% | 4.56% |
| Revvity, Inc. (RVTY)vs › | $12.31B | 2.01% | 2.19% | 1.89% | 3.83% |
| Align Technology, Inc. (ALGN)vs › | $12.29B | 6.81% | 6.68% | 6.69% | 12.75% |
| Baxter International Inc. (BAX)vs › | $11.93B | -5.53% | -3.64% | -1.62% | 0.47% |
| Insulet Corp. (PODD)vs › | $11.65B | 10.14% | 10.65% | 7.37% | 5.11% |
| Bio-Techne Corporation (TECH)vs › | $11.22B | 4.30% | 4.54% | 7.94% | 8.21% |
| Medpace Holdings, Inc. (MEDP)vs › | $16.70B | 23.89% | 21.05% | 19.32% | 16.45% |
| Charles River Laboratories International, Inc. (CRL)vs › | $10.93B | -2.39% | -0.94% | 2.58% | 3.75% |
ROA
10.2%
ROE
28.8%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 10.89% |
| 2024-12-31 | 3.31% |
| 2023-12-31 | 9.65% |
| 2022-12-31 | 9.88% |
| 2021-12-31 | 10.37% |
| 2020-12-31 | 0.00% |
